Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 34Recruiting 18Active not recruiting 6Not yet recruiting 4Enrolling by invitation 3Unknown 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Lung Neoplasms 1Liver Neoplasms 1Fibrosis 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Cisplatin 9Standard of Care 6Educational Status 6Nivolumab 5Interviews as Topic 5Carboplatin 5Radiotherapy 4Paclitaxel 4Oxaliplatin 4Fluorodeoxyglucose F18 4Dexamethasone 4pembrolizumab 3camrelizumab 3Practice Guidelines as Topic 3Patient Navigation 3Methods 3Magnetic Resonance Spectroscopy 3Magnetic Resonance Imaging 3Lenalidomide 3Fluorouracil 3Exercise 3Early Intervention, Educational 3Drug Therapy 3Cytarabine 3130-nm albumin-bound paclitaxel 3venetoclax 2toripalimab 2tislelizumab 2sacituzumab govitecan 2lenvatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Enrolling by invitation × Interventional × Patient Navigation × Clear all
NCT06324110 2026-05-18

Evaluating the Impact of Centralized Interventions on Lung Cancer Screening Adherence in Community Settings, ACCELL Trial

Fred Hutchinson Cancer Center

Phase NA Enrolling by invitation
6,772 enrolled
Thoracic

Lung Neoplasms

NCT06458998 2026-02-23

GTI

University of Pittsburgh

Phase NA Enrolling by invitation
30,300 enrolled
Gastrointestinal

Colonic Neoplasms, Fibrosis, Liver Neoplasms

NCT07230795 2025-11-17

AI-informed Colorectal Cancer (CRC) Screening Navigation vs. Standard of Care Among Screening-naive Penn Medicine Patients 45-49 Years Old to Increase CRC Screening Uptake

Abramson Cancer Center at Penn Medicine

Phase NA Enrolling by invitation
7,120 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡